A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities.
作者信息
Iyer Rugmani Padmanabhan, Lindsey Merry L, Chilton Robert J
机构信息
San Antonio Cardiovascular Proteomics Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
出版信息
J Clin Hypertens (Greenwich). 2013 Jul;15(7):455-7. doi: 10.1111/jch.12112. Epub 2013 Apr 29.
Abstract
摘要
相似文献
1
A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities.
J Clin Hypertens (Greenwich). 2013 Jul;15(7):455-7. doi: 10.1111/jch.12112. Epub 2013 Apr 29.
2
Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.
Jpn Circ J. 2001 Apr;65(4):305-9. doi: 10.1253/jcj.65.305.
3
The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
J Clin Hypertens (Greenwich). 2013 Feb;15(2):133-42. doi: 10.1111/jch.12042. Epub 2012 Dec 10.
4
Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Clin Exp Hypertens. 2003 Nov;25(8):525-35. doi: 10.1081/ceh-120025336.
5
Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.
J Clin Hypertens (Greenwich). 2013 Jul;15(7):465-72. doi: 10.1111/jch.12113. Epub 2013 Apr 29.
6
Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine.
Future Cardiol. 2019 Jul;15(4):259-266. doi: 10.2217/fca-2019-0008. Epub 2019 Jun 10.
7
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
Int J Mol Sci. 2013 Aug 16;14(8):16866-81. doi: 10.3390/ijms140816866.
8
[Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
MMW Fortschr Med. 2001 Jun 21;143(25):58.
9
10
Lacidipine and circadian variation in blood pressure: considerations for therapy.
J Cardiovasc Pharmacol. 1991;17 Suppl 4:S20-5; discussion S25-6.
引用本文的文献
1
Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials.
Cureus. 2021 Nov 22;13(11):e19822. doi: 10.7759/cureus.19822. eCollection 2021 Nov.
2
Single-pill combination of cilnidipine, an L-/N-type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE-Combi survey.
J Clin Hypertens (Greenwich). 2020 Mar;22(3):457-464. doi: 10.1111/jch.13771.
3
A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients.
J Clin Diagn Res. 2017 May;11(5):FC01-FC05. doi: 10.7860/JCDR/2017/23825.9763. Epub 2017 May 1.
本文引用的文献
1
Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.
J Clin Hypertens (Greenwich). 2013 Jul;15(7):465-72. doi: 10.1111/jch.12113. Epub 2013 Apr 29.
2
Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
Hypertens Res. 2013 Apr;36(4):342-8. doi: 10.1038/hr.2012.187. Epub 2012 Nov 29.
3
Beta-blockers for hypertension.
Cochrane Database Syst Rev. 2012 Nov 14;11:CD002003. doi: 10.1002/14651858.CD002003.pub4.
4
Cilnidipine regulates glucose metabolism and levels of high-molecular adiponectin in diet-induced obese mice.
Hypertens Res. 2013 Mar;36(3):196-201. doi: 10.1038/hr.2012.141. Epub 2012 Oct 11.
5
Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
J Hypertens. 2012 Sep;30(9):1845-55. doi: 10.1097/HJH.0b013e3283567645.
6
Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
Hypertens Res. 2012 Nov;35(11):1058-62. doi: 10.1038/hr.2012.96. Epub 2012 Jul 5.
7
The efficacy and safety of cilnidipine on mild to moderate essential hypertension: a systematic review and meta-analysis of randomized controlled trials in Chinese patients.
Cardiovasc Hematol Disord Drug Targets. 2012 Sep;12(1):56-62. doi: 10.2174/187152912801823165.
8
MRI of a novel murine working heart transplant model.
Circ Heart Fail. 2009 May;2(3):272-4. doi: 10.1161/CIRCHEARTFAILURE.109.852707.
9
Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.
Cardiovasc Ther. 2009 Summer;27(2):124-39. doi: 10.1111/j.1755-5922.2009.00079.x.
10
Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction.
Hypertens Res. 2005 Apr;28(4):361-8. doi: 10.1291/hypres.28.361.
Zotero 插件